Accountable Care Organizations Rapidly Changing Healthcare Marketplace
CHAPEL HILL, N.C., Jan. 16, 2015 /PRNewswire/ -- The Affordable Care Act has had an enormous impact on the U.S. Healthcare Industry, including accelerating the formation of new forms of provider networks. Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs) have challenged Biopharmaceutical and Medical Device companies to adapt their success, pricing and service delivery systems to reflect the rising influence of these networks.
According to recent research by benchmarking firm, Best Practices, LLC, more than 40% of benchmarked companies plan to expand into ACO networks. ACOs are currently underserved relative to other types of delivery networks. Due to the rapid growth of these organizations, pharmaceutical organizations may consider investigating these critical delivery networks more.
The related report, "Reshaping Commercial Models to Serve ACOs, IDNs & Emerging Provider Networks," distills insights on how organizations are adjusting and utilizing their staffing to best serve ACOs/IDNs.
Key study topics covered include:
- Resource deployment
- Change management activities
- Sales force structure
- Coordination and knowledge sharing
- Customer targeting and segmentation
- Understanding care delivery models
- Identifying decision makers
- Strategies to improve performance
- Employing health outcomes
- Lessons learned and trends
This study engaged 36 leaders at 31 pharma and medical device companies through a benchmarking survey. Analysts also conducted in-depth executive interviews to develop qualitative findings and insights.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1329.htm
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website: http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.